Dynavax Technologies Corporation (NASDAQ:DVAX), a biopharmaceutical company with a market capitalization of $1.73 billion and strong financial health according to InvestingPro analysis, announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback